Chelation therapy may result in death.
The U.S. Food and Drug Administration does not approve the use of chelation therapy to treat autism. This case study describes a 5-year-old boy with autism who was given chelation therapy. The boy died from a heart attack. This is the second case of a child dying from chelation therapy. The authors conclude that doctors should know that there are two types of EDTA chelation therapies and that one is more dangerous than the other.